• MJHLS Brand Logo

© 2021 MJH Life Sciences™ and Contemporary Clinic. All rights reserved.

PCSK9 Inhibitors: The Role of the Pharmacist in Coordinating Care and Improving Access

January 22nd 2022

This webinar will highlight strategies pharmacists can use and recommend in order to address and overcome barriers to access and optimize outcomes for patients with hyperlipidemia.

The Relationship Between Anemia and Cancer: Opportunities for Pharmacists to Improve Patient Outcomes

July 18th 2021

This webinar will outline the prevalence of cancer-related anemia and iron deficiency anemia as well as the associated complications for patients with cancer.

PCSK9 Inhibitors: Exploring Treatment Options for Hyperlipidemia and Optimizing Patient Care

January 14th 2022

This webinar will examine the current FDA-approved PCSK9 inhibitors with clinical trial data on safety and efficacy and real-world data for the management of hyperlipidemia.

Clinical Updates on the Rapid Advancements in COVID-19 Care: Vaccine Uptake and the Retail Pharmacist

February 13th 2022

This educational activity will provide pharmacists with an understanding of the reasons for vaccine hesitancy as well as an in-depth review of the status of efforts to develop a COVID-19 vaccine including considerations for storage, administration, and adverse effect monitoring.

PARP Inhibition: Current and Emerging Indications for Use in Ovarian, Breast, Pancreatic, and Prostate Cancers

July 8th 2021

This webinar will define the role of biomarkers and genetic testing in the selection of patients who may benefit from treatment with a PARP inhibitor.

PCSK9 Inhibitors: The Need for a Patient-Centered Approach to Hyperlipidemia Management

January 7th 2022

This activity highlights an overview of hyperlipidemia and updated guideline recommendations for healthcare professionals as they are intricately involved in identifying appropriate candidates for PCSK9 inhibitor therapy, educating patients, monitoring clinical responses, and working with clinicians to implement crucial interventions.
 

Advances in the Management of Metastatic Non-Small Cell Lung Cancer in the Era of Immune Checkpoint Inhibitors

July 7th 2021

Through this activity, learners will gain an understanding of tumor genome testing in non-small cell lung cancer and will also become familiar with the place in therapy for immune checkpoint inhibitors.

Bloodborne Pathogens and Essentials of COVID-19 Vaccine Storage and Administration

January 8th 2022

This activity is part of a 10-hour curriculum that will equip pharmacists and pharmacy technicians with CDC-recommended training as vaccination providers and will highlight the most current prevention strategies, testing options, treatment agents, and the utility of approved and emerging vaccines.

Bloodborne Pathogens and Essentials of COVID-19 Vaccine Storage and Administration

January 8th 2022

This activity is part of a 10-hour curriculum that will equip pharmacists and pharmacy technicians with CDC-recommended training as vaccination providers and will highlight the most current prevention strategies, testing options, treatment agents, and the utility of approved and emerging vaccines.

Safety and Efficacy of COVID-19 Vaccines: Understanding the Clinical Trials

January 8th 2022

This activity is part of a 10-hour curriculum that will equip pharmacists and pharmacy technicians with CDC-recommended training as vaccination providers and will highlight the most current prevention strategies, testing options, treatment agents, and the utility of approved and emerging vaccines.